Search Results 341-350 of 15941 for SC
... SC dose at Week 2 [or one 80 mg SC dose at Baseline, followed by one 40 mg SC dose at Week 2, in countries where this dosing regimen is approved]); OR; At ...
... SC dose at Week 0, followed by one 40 mg SC dose at Week 2, in countries where this dosing regimen is approved]);; At least one 4-week induction regimen ...
Saad A, Dietz AB, Herrmann SMS, Hickson LJ, Glockner JF, McKusick MA, Misra S, Bjarnason H, Armstrong AS, Gastineau DA, Lerman LO, Textor SC. Autologous ...
... (SC) for an additional 20 Weeks after completing the 32 Week study assessments post-randomization, while they continue with their background HES therapy per ...
... SC, Rafael G, Tran S, Baum A, Kyratsous CA, Peng KW, Russell SJ. IMMUNO-COV ... Concilio SC, Russell SJ, Peng KW. A brief review of reporter gene ...
Ilyas Aleem, M.D., M.Sc., was recently awarded the prestigious Cervical Spine Research Society traveling fellowship for 2019.
MTX: ≥ 15 mg/week subcutaneous (SC) or intramuscular (IM); ... At least one 4-week induction regimen of golimumab (200 mg SC at Week 0 and 100 mg SC at Week 2); ...
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...
... SC, Tan BR, Wise PE, Silviera ML, Smith RK, Suresh R, Byrnes K, Samson PP, Badiyan SN, Henke LE, Mutch MG, Kim H. Circumferential Resection Margin as ...
This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Solution. Back to top ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.